Clinical Development & Late Stage Research

Wenda Brennan, RPh, Vice President, Global Safety & Pharmacovigilance - March 14, 2019
Traditionally, sources of adverse event reporting included the clinical trial investigator sites, post marketing medical information call centers, and local QPs in Europe.  However, currently, potential adverse event reporting is...
Tagged in:
Aaron Berger, PMP, SSGB, Senior Director Safety, Epidemiology, Registries and Risk Management - February 22, 2019
Last week, leaders and scientists from the biotech and pharmaceutical industry gathered in San Francisco at the Outsourcing in Clinical Trials - West Coast Conference to share ideas and discuss recent trends in the clinical trial...
Tagged in:
Wenda Brennan, RPh, Vice President, Global Safety & Pharmacovigilance - February 06, 2019
Pharmaceutical and biotech companies benefit from working with external partners to manage pharmacovigilance activities. The breadth and scope of required services can depend on the mix of investigational and marketed products, the...
Tagged in:
- February 01, 2019
UBC – Your Oncology Partner February 4th is World Cancer Day, a global event on which we are united to spread awareness, education, and hope as it relates to this insidious disease. World Cancer Day highlights the idea that...
Tagged in:
Van Zyl Engelbrecht, Clinical Project Director in the EU - January 22, 2019
UBC’s Clinical Project Director in the EU, Van Zyl Engelbrecht, recently took part in a PharmaVOICE podcast on, “Successfully Managing & Implementing Orphan Drug Development Programs.” The presentation included the following...
Tagged in: